Literature DB >> 21792535

The past, present, and future of genetic associations in type 1 diabetes.

Peter R Baker1, Andrea K Steck.   

Abstract

Type 1 diabetes mellitus (T1DM) is an autoimmune disease affecting approximately one in 300 individuals in the United States. The majority of genetic research to date has focused on the heritability that predisposes to islet autoimmunity and T1DM. The evidence so far points to T1DM being a polygenic, common, complex disease with major susceptibility lying in the major histocompatibility complex (MHC) on chromosome 6 with other smaller effects seen in loci outside of the MHC. With recent advances in technology, novel means of exploring the human genome have given way to new information in the development of T1DM. The newest technologies, namely high-throughput polymorphism typing and sequencing, have led to a paradigm shift in studying common diseases such as T1DM. In this review we highlight the advances in genetic associations in T1DM in the last several decades and how they have led to a better understanding of T1DM pathogenesis.

Entities:  

Mesh:

Year:  2011        PMID: 21792535     DOI: 10.1007/s11892-011-0212-0

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  62 in total

1.  Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium.

Authors: 
Journal:  Nature       Date:  1999-10-28       Impact factor: 49.962

Review 2.  The allelic architecture of human disease genes: common disease-common variant...or not?

Authors:  Jonathan K Pritchard; Nancy J Cox
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

Review 3.  Genetics of type 1A diabetes.

Authors:  Patrick Concannon; Stephen S Rich; Gerald T Nepom
Journal:  N Engl J Med       Date:  2009-04-16       Impact factor: 91.245

Review 4.  Peripheral-antigen-expressing cells in thymic medulla: factors in self-tolerance and autoimmunity.

Authors:  D Hanahan
Journal:  Curr Opin Immunol       Date:  1998-12       Impact factor: 7.486

5.  Common susceptibility and transmission pattern of human leukocyte antigen DRB1-DQB1 haplotypes to Korean and Caucasian patients with type 1 diabetes.

Authors:  Y Park; J X She; C Y Wang; H Lee; S Babu; H A Erlich; J A Noble; G S Eisenbarth
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

6.  Extreme genetic risk for type 1A diabetes.

Authors:  Theresa A Aly; Akane Ide; Mohamed M Jahromi; Jennifer M Barker; Maria S Fernando; Sunanda R Babu; Liping Yu; Dongmei Miao; Henry A Erlich; Pamela R Fain; Katherine J Barriga; Jill M Norris; Marian J Rewers; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

7.  A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk.

Authors:  Matthias Heinig; Enrico Petretto; Chris Wallace; Leonardo Bottolo; Maxime Rotival; Han Lu; Yoyo Li; Rizwan Sarwar; Sarah R Langley; Anja Bauerfeind; Oliver Hummel; Young-Ae Lee; Svetlana Paskas; Carola Rintisch; Kathrin Saar; Jason Cooper; Rachel Buchan; Elizabeth E Gray; Jason G Cyster; Jeanette Erdmann; Christian Hengstenberg; Seraya Maouche; Willem H Ouwehand; Catherine M Rice; Nilesh J Samani; Heribert Schunkert; Alison H Goodall; Herbert Schulz; Helge G Roider; Martin Vingron; Stefan Blankenberg; Thomas Münzel; Tanja Zeller; Silke Szymczak; Andreas Ziegler; Laurence Tiret; Deborah J Smyth; Michal Pravenec; Timothy J Aitman; Francois Cambien; David Clayton; John A Todd; Norbert Hubner; Stuart A Cook
Journal:  Nature       Date:  2010-09-08       Impact factor: 49.962

8.  Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes.

Authors:  Christopher E Lowe; Jason D Cooper; Todd Brusko; Neil M Walker; Deborah J Smyth; Rebecca Bailey; Kirsi Bourget; Vincent Plagnol; Sarah Field; Mark Atkinson; David G Clayton; Linda S Wicker; John A Todd
Journal:  Nat Genet       Date:  2007-08-05       Impact factor: 38.330

9.  Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A.

Authors:  Sergey Nejentsev; Joanna M M Howson; Neil M Walker; Jeffrey Szeszko; Sarah F Field; Helen E Stevens; Pamela Reynolds; Matthew Hardy; Erna King; Jennifer Masters; John Hulme; Lisa M Maier; Deborah Smyth; Rebecca Bailey; Jason D Cooper; Gloria Ribas; R Duncan Campbell; David G Clayton; John A Todd
Journal:  Nature       Date:  2007-11-14       Impact factor: 49.962

10.  Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci.

Authors:  Jason D Cooper; Deborah J Smyth; Adam M Smiles; Vincent Plagnol; Neil M Walker; James E Allen; Kate Downes; Jeffrey C Barrett; Barry C Healy; Josyf C Mychaleckyj; James H Warram; John A Todd
Journal:  Nat Genet       Date:  2008-11-02       Impact factor: 38.330

View more
  4 in total

Review 1.  New opportunities: harnessing induced pluripotency for discovery in diabetes and metabolism.

Authors:  Adrian Kee Keong Teo; Amy J Wagers; Rohit N Kulkarni
Journal:  Cell Metab       Date:  2013-09-12       Impact factor: 27.287

2.  Detecting rare variant associations by identity-by-descent mapping in case-control studies.

Authors:  Sharon R Browning; Elizabeth A Thompson
Journal:  Genetics       Date:  2012-01-20       Impact factor: 4.562

Review 3.  Making the most of major histocompatibility complex molecule multimers: applications in type 1 diabetes.

Authors:  Greg S Gojanovich; Paul R Hess
Journal:  Clin Dev Immunol       Date:  2012-05-28

4.  Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms.

Authors:  Anna Grohová; Klára Dáňová; Irena Adkins; Zdeněk Šumník; Lenka Petruželková; Barbora Obermannová; Stanislava Koloušková; Radek Špíšek; Lenka Palová-Jelínková
Journal:  PLoS One       Date:  2020-11-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.